PP_1170x120_10-25-21

Figures and Trends

2021 Specialty Pharmaceutical Distribution Factbook now available

2021 Specialty Pharmaceutical Distribution Factbook now available

ARLINGTON, Va. — Data published Thursday by the Healthcare Distribution Alliance (HDA) Research Foundation indicate HDA-member specialty distributors adapted to ensure reliable delivery of complex medications during the first year of the COVID-19 response. As reported in the 2021 edition of Specialty Pharmaceutical Distribution Facts, Figures and Trends, individual specialty distributors serve as a critical

HDA Research Foundation quantifies efficiencies provided by specialty Rx distributors

HDA Research Foundation quantifies efficiencies provided by specialty Rx distributors

ARLINGTON, Va. — New data released today by the HDA Research Foundation illustrate the continued supply chain efficiencies generated by HDA-member specialty distributors. According to the latest edition of Specialty Pharmaceutical Distribution: Facts, Figures and Trends, specialty distributors are a vital nexus between 176 manufacturers and more than 49,000 provider ship-to points for administration or dispensing to patients.

Analysis of HDA specialty distributors reveals continued growth

Analysis of HDA specialty distributors reveals continued growth

ARLINGTON, Va. — A new analysis published by the HDA Research Foundation indicates that oncology drugs, autoimmune and HIV therapeutics fueled specialty pharmaceutical segment growth in 2018. The 2019 Specialty Pharmaceutical Distribution: Facts, Figures and Trends indicates that oncology therapeutics account for most specialty distributor sales at 48.4%. “Specialty drugs account for nearly half of